Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
BMC Surg ; 19(1): 185, 2019 Dec 03.
Article in English | MEDLINE | ID: mdl-31795997

ABSTRACT

BACKGROUND: As there is no consensus on the optimal surgery strategy for multiple primary lung cancer (MPLC), we conducted this study to address this issue by comparing the prognosis of MPLC patients underwent different surgical strategies including sublobar resection and the standard resection through a systemic review and meta-analysis. METHODS: Relevant literature was obtained from three databases including PubMed, Embase and Web of Science. Inclusion and exclusion criteria were set for the screening of articles to be selected for further conduction of systemic review and meta-analysis. The HRs of OS of the sublobar group compared with standard resection group were extracted directly or calculated indirectly from included researches. RESULTS: Ten researches published from 2000 to 2017 were included in this study, with 468 and 445 MPLC cases for the standard resection group and sublobar resection group respectively. The result suggested that OS of MPLC patients underwent sublobar resection (segmentectomy or wedge resection for at least one lesion) was comparable with those underwent standard resection approach (lobectomy or pneumonectomy for all lesions), with HR 1.07, 95% CI 0.67-1.71, p = 0.784. Further analysis found no difference in subgroups of synchronous and metachronous (from second metachronous lesion), different population region and dominant sex type. CONCLUSIONS: This study may reveal that sublobar resection is acceptable for patients with MPLC at an early stage, because of the equivalent prognosis to the standard resection and better pulmonary function preservation. Further research is needed to validate these findings.


Subject(s)
Lung Neoplasms/surgery , Neoplasms, Multiple Primary/surgery , Pneumonectomy/methods , Humans , Neoplasm Staging , Prognosis
2.
Zhong Yao Cai ; 34(7): 1060-2, 2011 Jul.
Article in Chinese | MEDLINE | ID: mdl-22066399

ABSTRACT

OBJECTIVE: To study the chemical constituents of Pithecellobium clypearia. METHODS: Silica gel column chromatography and Sephadex LH-20 were used to separate and purify compounds from the EtOAc soluble fraction of Pithecellobium clypearia. 9 compounds were elucidated on the basis of physicochemical properties and spectrascopic analysis. RESULTS: They were identified as beta-Sitosterol (1), tritriacontane (2), 5-hydroxy-3,7,3',4'-tetramethoxyflavone (3), oleanolic acid (4), 5,4'-dihydroxy-3,7,3'-trimethoxyflavone (5), alpha-amyrin (6), luteolin (7), ursolic acid (8), luteoloside (9). CONCLUSION: Compounds 3 and 5 are isolated from this plant for the first time.


Subject(s)
Fabaceae/chemistry , Flavonoids/isolation & purification , Plants, Medicinal/chemistry , Flavonoids/chemistry , Molecular Structure , Oleanolic Acid/chemistry , Oleanolic Acid/isolation & purification , Paraffin/chemistry , Paraffin/isolation & purification , Plant Leaves/chemistry , Plant Stems/chemistry
3.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 19(5): 1246-9, 2011 Oct.
Article in Chinese | MEDLINE | ID: mdl-22040981

ABSTRACT

This study was aimed to analyze the BP1 binding site sequence upstream of ß-globin gene in Chinese Han population, and to investigate polymorphism in the BP1 binding site upstream of ß-globin gene, so as to provide the basis for exploration of relation between polymorphisms in the BP1 binding site and ß-globin expression. Genomic DNA was extracted from peripheral leukocytes of 110 healthy individuals in Chinese Han population. Sequence of the BP1 binding site upstream of ß-globin gene was amplified by polymerase chain reaction, the polymorphic variation in the BP1 binding site was determined by DNA sequencing. The results indicated that 2 polymorphism loci were found in the BP1 binding site upstream of ß-globin gene, they were C/T at the -551 bp region and (AC)(n)(AT)(x)T(y) at the -530 bp region in Chinese Han population. Frequencies of C and T were 60.4% and 39.6% at position -551. Analysis of the (AC)(n)(AT)(x)T(y) polymorphism revealed 9 different genotypes: (AC)(2)(AT)(9)T(5), (AC)(2)(AT)(8)T(5), (AC)(2)(AT)(7)T(7), (AC)(3)(AT)(7)T(5), (AC)(2)(AT)(8)T(9), (AC)(3)(AT)(8)T(5), (AC)(2)(AT)(10)T(3), (AC)(2)(AT)(11)T(3), and (AC)(2)(AT)(7)T(5) at position -530. Frequencies of 9 (AC)(n)(AT)(x)T(y) polymorphisms were 33.2%, 29.1%, 24.1%, 5.4%, 3.2%, 1.8%, 1.4%, 0.9%, and 0.9% respectively. It is concluded that rich (AC)(n)(AT)(x)T(y) polymorphisms at the -530 bp region in the BP1 binding site upstream of ß-globin gene are found in Chinese Han population. (AC)(2)(AT)(9)T(5), (AC)(2)(AT)(8)T(5), and (AC)(2)(AT)(7)T(7) are 3 major polymorphisms among Chinese Han population, and (AC)(3)(AT)(8)T(5) is a novel polymorphism at the -530 bp region. More studies should be done to explore relation between (AC)(n)(AT)(x)T(y) polymorphisms and ß-globin expression.


Subject(s)
Binding Sites/genetics , Polymorphism, Genetic , beta-Globins/genetics , Adult , Asian People/genetics , Base Sequence , Female , Gene Frequency , Genotype , Humans , Male , Middle Aged , Molecular Sequence Data
4.
Yakugaku Zasshi ; 131(9): 1383-94, 2011.
Article in English | MEDLINE | ID: mdl-21881314

ABSTRACT

  Î´-Elemene, an antitumor component, is a chemical compound isolated from Curcuma wenyujin, a Chinese traditional herb. We examined whether δ-elemene could inhibit cell growth and cell cycle progression and induce apoptosis in human leukemia HL-60 cells. The results demonstrated that δ-elemene induces significant apoptosis of HL-60 cells, as shown by MTT assay, annexin V (AnV) binding of externalized phosphatidylserine (PS), and the mitochondrial probe JC-1 using flow cytometry. HL-60 cells treated with δ-elemene showed high percentages in the early apoptotic and late apoptoctic/necrotic stages, as well as caspase-3 activation of HL-60 cells. By monitoring the changes in cell cycle profiles, we confirmed that δ-elemene could interfere with the cell cycle in the G2/M phase and induce apoptosis in HL-60 cells in a time-dependent manner. Caspase-3 plays a direct role in proteolytic cleavage of the cellular proteins responsible for progression to apoptosis. Therefore we examined apoptosis in HL-60 cells after exposure to δ-elemene and measured caspase-3 activities with or without Z-Val-Ala-Asp-fluoromethylketone (z-VAD-fmk, a broad-spectrum caspase inhibitor) pretreatment using flow cytometric analysis. The results showed that δ-elemene could induce caspase-3 activation as detected by the decrease in δ-elemene-induced caspase-3 activities after treatment with z-VAD-fmk. In the present study, δ-elemene activated typical caspase-dependent apoptosis in HL-60 cells, as demonstrated by an inhibitory effect of z-VAD-fmk on this cell death. During δ-elemene-induced apoptosis, cytochrome c and apoptosis-inducing factor were released into the cytosol and BAX was translocated from the cytosol to mitochondria. However, these were not prevented by z-VAD-fmk. In conclusion, our study demonstrated that δ-elemene could induce G2/M cell cycle transition and trigger apoptosis through a caspase-3-dependent pathway.


Subject(s)
Apoptosis/drug effects , Caspase 3/physiology , HL-60 Cells/enzymology , HL-60 Cells/pathology , Sesquiterpenes/pharmacology , Amino Acid Chloromethyl Ketones/pharmacology , Caspase 3/metabolism , Cell Division/drug effects , Cell Line, Tumor , Curcuma/chemistry , Cytochromes c/metabolism , Cytosol/metabolism , Dose-Response Relationship, Drug , G2 Phase/drug effects , Humans , Membrane Potential, Mitochondrial/drug effects , Membrane Potential, Mitochondrial/physiology , Mitochondria/metabolism , Sesquiterpenes/antagonists & inhibitors , Sesquiterpenes/isolation & purification , Time Factors , bcl-2-Associated X Protein/metabolism
5.
Biol Pharm Bull ; 34(8): 1279-86, 2011.
Article in English | MEDLINE | ID: mdl-21804218

ABSTRACT

δ-Elemene, an antitumor component, is a chemical compound isolated from Curcuma wenyujin, a Chinese traditional herb. We examined whether δ-elemene could affect apoptosis in human lung carcinoma mucoepidermoid NCI-H292 cells, and test whether and how the over-expression of B-cell lymphoma-2 (Bcl-2) and B-cell lymphoma extra large (Bcl-xL) could off-set the effect of δ-elemene on cell growth. The result demonstrated that δ-elemene significantly induced apoptosis of NCI-H292, as shown by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, DNA fragmentation measurement, Annexin V (AnV) binding of externalized phosphatidylserine and the mitochondrial probe JC-1 using flow cytometry. Treatment of NCI-H292 with δ-elemene increased both p38 mitogen-activated protein kinase (MAPK) and inducible nitric oxide synthese (iNOS) levels, suggesting these two molecules maybe relate to the apoptotic effect of δ-elemene. The cells with Bcl-2 or Bcl-xL over-expression showed an elevation of nuclear factor kappa B (NF-kappa B) activity, accompanying a significant reduction of δ-elemene-induced apoptosis. Furthermore, inhibition of NF-kappa B by IkBαSR, which is a powerful inhibitor of NF-kappa B, restored the ability of δ-elemene to induce apoptosis in the cells transfected with Bcl-2. These data strongly indicated that the apoptotic effect of δ-elemene on NCI-H292 was closely associated with the activity of NF-kappa B, which was up-regulated by Bcl-2 and Bcl-xL. In conclusion, δ-elemene induced apoptosis in NCI-H292 cells. The apoptotic effect of δ-elemene could be significantly offset by over-expression of either Bcl-2 or Bcl-xL. Bcl-2 and Bcl-xL were able to increase the activity of NF-kappa B, which was a known anti-apoptotic molecule in human lung cancer cells.


Subject(s)
Apoptosis/drug effects , Carcinoma, Mucoepidermoid/metabolism , Curcuma/chemistry , Lung Neoplasms/metabolism , NF-kappa B/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Sesquiterpenes/pharmacology , Antineoplastic Agents, Phytogenic/pharmacology , Antineoplastic Agents, Phytogenic/therapeutic use , Carcinoma, Mucoepidermoid/drug therapy , Cell Line, Tumor , DNA Fragmentation , Drugs, Chinese Herbal/pharmacology , Drugs, Chinese Herbal/therapeutic use , Flow Cytometry , Humans , Lung Neoplasms/drug therapy , Nitric Oxide Synthase Type II/metabolism , Phytotherapy , Sesquiterpenes/therapeutic use , Signal Transduction/drug effects , bcl-X Protein/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism
6.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi ; 28(4): 409-13, 2011 Aug.
Article in Chinese | MEDLINE | ID: mdl-21811981

ABSTRACT

OBJECTIVE: To analyze the coding sequence of GJB2 gene in six pedigrees with nonsyndromic hearing loss in order to find deafness-causing mutations in the GJB2 gene, and to explore the inherent pattern of deafness-causing mutations in the GJB2 gene. METHODS: Genomic DNA was extracted from peripheral blood for the probands and their family members. Coding sequence of the GJB2 gene was amplified by polymerase chain reaction, sequence variations were determined by DNA sequencing. Amplified fragments with overlapping peaks on sequencing chromatogram were sequenced by TA cloning in order to determine whether the mutations originated from the same allele. RESULTS: Mutations in the GJB2 gene were found in 4 out of the 6 pedigrees with nonsyndromic hearing loss. Four types of mutations were detected in the GJB2 gene, which were 235delC, 299-300delAT, 79G>A+341A>G, and 109G>A. Compound heterozygous polymorphisms 79G>A and 341A>G, and mutations 109G>A and 235delC had deafness-causing effects. CONCLUSION: Heterogeneous mutations of the GJB2 gene are frequently seen in patients with nonsyndromic hearing loss. Sometimes, polymorphisms may cause deafness when they are combined. Environmental factors and other genes may contribute to hearing loss caused by the GJB2 gene mutations.


Subject(s)
Connexins/genetics , DNA Mutational Analysis , Hearing Loss/genetics , Base Sequence , Connexin 26 , Female , Humans , Inheritance Patterns/genetics , Male , Pedigree
7.
Yakugaku Zasshi ; 129(11): 1403-13, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19881213

ABSTRACT

The chemical compound delta-elemene, isolated from the Chinese herbal medicine plant Curcuma Wenyujin, has been known to exert antitumor activity. In this study we demonstrated that apoptotic cell death induced by delta-elemene in DLD-1 cells was concentration-and time-dependent, and had little inhibition of the normal human liver cell line WRL-68. Apoptosis was further confirmed and quantified by DNA fragmentation ELISA, Annexin V (AnV) binding of externalized phosphatidylserine and the mitochondrial probe JC-1 using flow cytometry. The rapid increase in intracellular reactive oxygen species (ROS) levels was involved in the mechanism of cell death. Western blot analysis demonstrated that delta-elemene activated the caspase-signaling pathway, leading to the proteolysis conversion of pro-caspase-3 to activate caspase-3, and the subsequent cleavage of the caspase substrate PARP. In the process of the induction of apoptotic cell death, Bax translocated into mitochondria, a reduction in Deltapsim was observed and a release of cytochrome c and apoptosis inducing factor (AIF) from mitochondria into the cytosol occurred, indicating that cell death induced by delta-elemene was through a mitochondrial-mediated pathway.


Subject(s)
Adenocarcinoma/pathology , Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Colorectal Neoplasms/pathology , Mitochondria/physiology , Sesquiterpenes/pharmacology , Caspase 3/metabolism , Cell Line, Tumor , Curcuma , Dose-Response Relationship, Drug , Humans , Poly(ADP-ribose) Polymerases/metabolism , Reactive Oxygen Species/metabolism , Time Factors
8.
Zhonghua Yi Xue Za Zhi ; 86(2): 124-7, 2006 Jan 10.
Article in Chinese | MEDLINE | ID: mdl-16620721

ABSTRACT

OBJECTIVE: To identify the genetic defect of coagulation factor VII in a Chinese family with hereditary FVII deficiency. METHODS: Peripheral blood samples were collected from the proband of hereditary FVII deficiency, female, aged 15, 4 members of her family, and 100 healthy persons. Genomic DNA was isolated. All the exons and exon-intron boundaries of FVII gene were amplified by PCR, then the PCR products were sequenced by direct sequencing. Restrictive endonuclease analysis was performed in all of the family members and the 100 healthy donors to exclude gene polymorphism. Biostructural analysis of the mutated FVII was completed by molecular modeling. RESULTS: Double heterozygous mutations in the proband were identified: A-->G mutation at position 10833 and C-->A mutation at position 9643, resulting in Met306Val and Thr181Asn substitution respectively. Heterozygosity for Met306Val was confirmed in the proband's mother and her elder sister; heterozygosity for Thr181Asn was confirmed in the proband's father. It was found by computer simulated molecular model that the Met306Val replacement, which was located on the surface of the FVII molecule, might cause steric hindrance and change the configuration and function of FVII protein. CONCLUSION: Double heterozygous mutations for Met306Val and Thr181Asn in FVII gene have been found in a proband with hereditary FVII deficiency. The Met306Val substitution in FVII gene is a novel mutation in hereditary FVII deficiency. The heterozygous mutation of FVII gene may change the configuration of FVII protein and result in FVII dysfunction.


Subject(s)
Factor VII Deficiency/genetics , Factor VII/genetics , Mutation , Adolescent , Amino Acid Substitution , Base Sequence , DNA Mutational Analysis , Factor VII/chemistry , Factor VII/metabolism , Factor VII Deficiency/blood , Family Health , Female , Heterozygote , Humans , Male , Models, Molecular , Molecular Sequence Data , Pedigree , Protein Structure, Tertiary
SELECTION OF CITATIONS
SEARCH DETAIL
...